Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes
- PMID: 19901172
- PMCID: PMC2909769
- DOI: 10.1001/archneurol.2009.252
Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes
Abstract
Objectives: To evaluate demographics, magnetic resonance imaging (MRI) measures, and vascular risk among mild cognitive impairment (MCI) subtypes.
Design: Cross-sectional study.
Setting: Both clinics and the community.
Participants: A total of 153 subjects with MCI, 218 cognitively normal older individuals (controls), and 68 patients with Alzheimer disease.
Main outcome measures: Classification of subjects with MCI according to current subtype diagnostic convention based on neuropsychological performance, estimates of vascular risk based on medical history, research MRI unless there was a specific contraindication, and apolipoprotein E genotype.
Results: Of the 153 subjects with MCI, 65 were diagnosed with amnestic single-domain, 46 with amnestic multiple-domain, 27 with nonamnestic single-domain, and 15 with nonamnestic multiple-domain MCI. Analyses of control, MCI, and Alzheimer disease cases revealed significant differences in brain and hippocampal volumes between each group. Post hoc analyses of MRI measures among the MCI subtypes found that patients with amnestic single-domain MCI had significantly less brain atrophy and that hippocampal volume differed significantly from controls for the 2 amnestic forms of MCI. Apolipoprotein E genotype prevalence was significantly greater in the amnestic and nonamnestic subtypes of MCI. Conversely, the nonamnestic subtypes were more likely to have increased vascular risk and to be African American.
Conclusions: Amnestic forms of MCI appear to have demographic, genetic, and MRI findings suggestive of Alzheimer disease pathology, whereas the nonamnestic forms of MCI have findings suggestive of vascular disease. Importantly, however, all subjects with MCI showed evidence of brain injury, and the biological differences among subtypes are relatively subtle beyond the memory vs nonmemory groupings.
Figures
Similar articles
-
Semantic memory activation in amnestic mild cognitive impairment.Brain. 2009 Aug;132(Pt 8):2068-78. doi: 10.1093/brain/awp157. Epub 2009 Jun 10. Brain. 2009. PMID: 19515831 Free PMC article.
-
Prevalence of four subtypes of mild cognitive impairment and APOE in a Japanese community.Int J Geriatr Psychiatry. 2009 Oct;24(10):1119-26. doi: 10.1002/gps.2234. Int J Geriatr Psychiatry. 2009. PMID: 19449451
-
Association of prior stroke with cognitive function and cognitive impairment: a population-based study.Arch Neurol. 2009 May;66(5):614-9. doi: 10.1001/archneurol.2009.30. Arch Neurol. 2009. PMID: 19433661 Free PMC article.
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment.Int Rev Neurobiol. 2009;84:81-103. doi: 10.1016/S0074-7742(09)00405-X. Int Rev Neurobiol. 2009. PMID: 19501714 Free PMC article. Review.
Cited by
-
The contributions of MRI-based measures of gray matter, white matter hyperintensity, and white matter integrity to late-life cognition.AJNR Am J Neuroradiol. 2012 Oct;33(9):1797-803. doi: 10.3174/ajnr.A3048. Epub 2012 Apr 26. AJNR Am J Neuroradiol. 2012. PMID: 22538073 Free PMC article.
-
Neuropsychological and neuroimaging characteristics of amnestic mild cognitive impairment subtypes: a selective overview.CNS Neurosci Ther. 2015 Oct;21(10):776-83. doi: 10.1111/cns.12391. Epub 2015 Mar 26. CNS Neurosci Ther. 2015. PMID: 25809732 Free PMC article. Review.
-
Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity.Int J Alzheimers Dis. 2012;2012:421452. doi: 10.1155/2012/421452. Epub 2012 Apr 9. Int J Alzheimers Dis. 2012. PMID: 22550605 Free PMC article.
-
Increased Hippocampal-Inferior Temporal Gyrus White Matter Connectivity following Donepezil Treatment in Patients with Early Alzheimer's Disease: A Diffusion Tensor Probabilistic Tractography Study.J Clin Med. 2023 Jan 27;12(3):967. doi: 10.3390/jcm12030967. J Clin Med. 2023. PMID: 36769615 Free PMC article.
-
Association of Homocysteine Levels With Medial Temporal Lobe Atrophy Among Carriers and Non-carriers of APOE ε4 in MCI Subjects.Front Psychiatry. 2022 Apr 12;13:823605. doi: 10.3389/fpsyt.2022.823605. eCollection 2022. Front Psychiatry. 2022. PMID: 35492717 Free PMC article.
References
-
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003;60(8):1119–1122. - PubMed
-
- Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA. State-specific projections through 2025 of Alzheimer disease prevalence. Neurology. 2004;62(9):1645. - PubMed
-
- Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41(7):1006–1009. - PubMed
-
- Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56(3):303–308. - PubMed
-
- DeCarli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2003;2(1):15–21. - PubMed